About Cutaneous Lymphoma

Yaupon Announces Positive Results From Pivotal Study of its Proprietary Topical Mechlorethamine Gel; A Potential Treatment for Early-Stage Cutaneous T-Cell Lymphoma

Fri, 09/24/2010